Table 2. Descriptive characteristics of sexual practice among men who have sex with men (n: 1,301) during the COVID-19 pandemic, considering chemsex*. Portugal, 2020.
Interest variables | Chemsex* | p-value† | |||||
---|---|---|---|---|---|---|---|
Yes | No | Total | |||||
n | % | n | % | N | % | ||
Social distancing period | |||||||
Duration of social isolation/distancing (days) | 0,060 | ||||||
Less than 29 | 44 | 16,7 | 114 | 11 | 158 | 12,1 | |
Between 30 and 45 | 116 | 44,1 | 502 | 48,4 | 618 | 47,5 | |
More than 45 | 88 | 33,5 | 374 | 36 | 462 | 35,5 | |
Did not adhere to social isolation | 15 | 5,7 | 48 | 4,6 | 63 | 4,9 | |
How many partners did you have since social distancing measures were imposed? | 0,001 | ||||||
None | 0 | 0 | 466 | 44,9 | 466 | 35,8 | |
1 partner | 20 | 7,6 | 397 | 38,2 | 417 | 32,0 | |
More than 2 | 243 | 92,4 | 175 | 16,9 | 418 | 32,2 | |
During the social distancing you: | |||||||
Had sex with penetration without condoms | 145 | 55,1 | 121 | 11,7 | 266 | 20,5 | 0,001 |
Paid for sexual intercourse | 16 | 6,1 | 35 | 3,4 | 51 | 3,9 | 0,043 |
Group sex (sex with 2 or more people simultaneously) | 156 | 59,3 | 35 | 3,4 | 191 | 14,7 | 0,001 |
Protective measures adopted in casual sex to prevent COVID-19 | |||||||
Avoided kissing during sexual intercourse | 147 | 55,9 | 195 | 18,8 | 342 | 48,7 | 0,003 |
Sanitized the place where you had sex | 143 | 54,4 | 198 | 19,1 | 344 | 48,8 | 0,017 |
Washed hands with water and soap | 148 | 56,3 | 197 | 19 | 345 | 49,9 | 0,003 |
Verified whether the sexual partner had signs and symptoms of COVID-19 | 158 | 60,1 | 457 | 35,1 | 615 | 63,7 | 0,031 |
Used PrEP ‡ / Truvada | 112 | 42,6 | 64 | 6,2 | 176 | 25,1 | 0,001 |
COVID-19 testing | |||||||
Yes | 83 | 31,6 | 167 | 16,1 | 250 | 19,2 | |
No | 180 | 68,4 | 871 | 83,9 | 1051 | 80,8 | 0,001 |
Diagnosed with COVID-19 | |||||||
Yes | 41 | 15,6 | 58 | 5,6 | 99 | 39,6 | 0,026 |
No | 42 | 16 | 109 | 10,5 | 151 | 60,4 |
* Chemsex = Sex under the influence of drugs; †p = Statistical significance obtained through a Chi-square test; ‡HIV = Human immunodeficiency Virus; §PrEP = Pre-exposure Prophylaxis